Momordicine-I, a Bitter Melon Bioactive Metabolite, Displays Anti-Tumor Activity in Head and Neck Cancer Involving c-Met and Downstream Signaling
Subhayan Sur(Saint Louis University), Ratna B. Ray(Saint Louis University)
Cited by 24
Related Papers
Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3
|Oncotarget|2016|187
Bitter melon extract inhibits breast cancer growth in preclinical model by inducing autophagic cell death
|Oncotarget|2017|137
miRNA-29b Inhibits Prostate Tumor Growth and Induces Apoptosis by Increasing Bim Expression
|Cells|2019|123
Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract
|Cell Communication and Signaling|2019|74
Identification of molecular signature of head and neck cancer stem-like cells
|Scientific Reports|2015|63